Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies


Shield and our collaborators actively publish and present new data. Please find key publications and posters below.

Filter by date

2016   |   Alimentary Pharmacology and Therapeutics

Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study

C Schmidt, T Ahmad, Z Tulassay, D C Baumgart, B Bokemeyer, S Howaldt, A Stallmach, C Büning, AEGIS Study Group

Read More

2021   |   BMJ Open Gastroenterology

Ferric maltol Real-world Effectiveness Study in Hospital practice (FRESH): clinical characteristics and outcomes of patients with inflammatory bowel disease receiving ferric maltol for iron-deficiency anaemia in the UK

Fraser Cummings, Aileen Fraser, Catherine Stansfield, Ian Beales, Shaji Sebastian, Sami Hoque

Read More

2021   |   Inflammatory Bowel Diseases

Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial

Stefanie Howaldt, MD, Eugeni Domènech, MD, PhD, Nicholas Martinez, MD, Carsten Schmidt, MD, Bernd Bokemeyer, MD on behalf of the AEGIS Trialists

Read More

2021   |   Journal of Clinical Medicine

Iron Replacement Therapy with Oral Ferric Maltol: Review of the Evidence and Expert Opinion

Carsten Schmidt, Stephen Allen, Nelson Kopyt and Pablo Pergola

Read More

2021   |   American journal of kidney diseases

Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label Extension

Pablo E Pergola, Nelson P Kopyt

Read More

2021   |   MDPI: Nutrients

Oral Ferric Maltol Does Not Adversely Affect the Intestinal Microbiome of Patients or Mice, but Ferrous Sulphate Does

Awad Mahalhal 1,* , Alessandra Fra, Michael D. Burkitt, Umer Z. Ijaz, Christopher A. Lamb, John C. Mansfield, Stephen Lewis, D. Mark Pritchard and Chris S. Probert

Read More

2021   |   Journal of Pediatric Gastroenterology and Nutrition

Safety, Tolerability, and Pharmacokinetics of Oral Ferric Maltol in Children With Iron Deficiency: Phase 1 Study

Allen, Stephen, Marcus, Karl-Heinz, Kim, Jon Jin, Vadamalayan, Babu

Read More

2020   |   Nephrology Dialysis Transplantation

Efficacy and safety of PT20, an iron-based phosphate binder, for the treatment of hyperphosphataemia: a randomized, double-blind, placebo-controlled, dose-ranging, Phase IIb study in patients with haemodialysis-dependent chronic kidney disease.

Mark Sampson, Nuno Faria, Jonathan J. Powell

Read More

2020   |   European Respiratory Journal

Oral iron supplementation with ferric maltol in patients with pulmonary hypertension

Karen M Olsson, Jan Fuge, Torben Brod, Jan C Kamp, Jan Schmitto, Tibor Kempf, Johann Bauersachs, Marius M Hoeper

Read More